Factors associated with prolonged prehospital delay of African Americans with acute myocardial infarction

Angela D Banks1, Kathleen Dracup

  • 1School of Nursing, University of San Francisco, San Francisco, CA, USA.

Insights

African Americans experience prolonged delays in seeking treatment for acute myocardial infarction (AMI). Factors like insurance status and marital status, not perceived racism, were linked to these delays, highlighting a need for patient and family education.

Area of Science:

  • Cardiology
  • Public Health
  • Health Disparities

Background:

  • African Americans experience longer delays in seeking treatment for acute myocardial infarction (AMI) compared to white individuals.
  • Prehospital delay in AMI treatment can lead to reduced therapeutic benefit and poorer outcomes.

Purpose of the Study:

  • To identify factors contributing to prolonged prehospital delay in African Americans with AMI.
  • To investigate the role of perceived racism in prehospital delay among African Americans experiencing AMI.

Main Methods:

  • A cohort of 61 African Americans with AMI were interviewed within one month of hospital admission.
  • Delay times were calculated, and statistical analyses (independent t tests, chi-squared tests) were used to identify factors associated with prolonged delays.

Main Results:

  • The median delay for seeking AMI treatment was 4.25 hours, significantly longer than the recommended <1 hour.
  • Factors associated with longer delays included being insured, single/widowed/divorced status, and having diabetes.
  • Perceived racism did not significantly influence prehospital delay in this cohort.

Conclusions:

  • Substantial delays in seeking AMI treatment among African Americans necessitate urgent interventions.
  • Patient and family education and counseling are crucial strategies to reduce prehospital delay and improve outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...